chrisvoncsefalvay/vaers-outcomes huggingface dataset:
DATE OF ADMISSION:  07/09/2022 DATE OF DISCHARGE:  07/22/2022   PROVISIONAL DIAGNOSES 1. Pneumonia. 2. Acute on chronic respiratory failure with hypoxemia. 3. Interstitial lung disease. 4. Smoking history with radiographic emphysema. 5. COVID-19 long-hauler. 6. History of B-cell lymphoma. 7. History of pancytopenia including leukopenia with neutropenia, anemia, and thrombocytopenia, all progressive.  HOSPITAL COURSE The patient is a very pleasant 57-year-old female with past medical history as listed above including follicular lymphoma with transformation to diffuse large B-cell lymphoma, on maintenance therapy, in remission, who presented to Spectrum Health Butterworth secondary to progressive shortness of breath.  She has had shortness of breath since her diagnosis of COVID-19 in May.  Initial laboratory studies and imaging can be found per review.  The patient's Film Array was negative other than COVID-19 PCR detected COVID-19.  Cycle threshold was low at 19.5, indicating active disease.  Chest x-ray on July 10 showed persistent infiltrates.  The patient was requiring high-flow oxygen and was admitted to the medical ICU team.  Infectious Disease was consulted.  The patient completed a course of remdesivir from 07/10 to 07/14.  Tocilizumab was not an option due to neutropenia.  We suspect persistent infection due to immunosuppression with Rituxan use.  She completed a course of cefepime and doxycycline on 07/15.  Chest x-ray on 07/13 showed slightly worsening multifocal pneumonia.  Chest x-ray on 07/18 showed persistent opacities unchanged and improvement was seen on July 21st chest x-ray.  The patient was transferred out of the ICU when her oxygenation improved.  Oncology assumed care.  She was treated per Pulmonary with Solu-Medrol and this has been transitioned to oral prednisone 60 mg daily with plan to continue at this dose until Pulmonary followup in 2 to 3 weeks.  PPI was added on steroids.  The patient's discharge was delayed due to increasing oxygen requirements with ambulation.  She is now only requiring 5 L with ambulation and is comfortable on 3 L at rest.  Facility is accepting patient.  Physical and Occupational Therapy were consulted and recommended SAR at discharge.
3 minutes post vaccination patient began complaining of dizziness. Child was breathing rapidly into his mask for the 3 min after being vaccinated and was very agitated and worked up. Father picked child up and he passed out for about 2 seconds. He immediately regained consciousness and continued to complain of dizziness for another 2 min. 10 min later all symptoms resolved. Advised follow up with Primary care provider.
Diarrhea for 10 days. There was  blood per rectum profuse with clots. Child is admitted to hospital. 04/17/07-records received from facility for DOS 3/15-3/21/07-DX:Gastroenteritis. No DC Summary available. Chief complaint bloody stool. Ten days prior had watery non bloody stools. Febrile episode with temperature of 102.4. Decreased appetite. No vomiting. Seen in PCP office, stool with bright red clots. PE: WNL, abdomen soft non distended. Bowel sounds in four quadrants. Diaper rash.
This case was reported by a consumer via interactive digital media and described the occurrence of tinnitus in a female patient who received HAB TWINRIX for prophylaxis. On an unknown date, the patient received TWINRIX at an unknown dose. On an unknown date, unknown after receiving TWINRIX, the patient experienced tinnitus and debility. On an unknown date, the outcome of the tinnitus and debility were not reported. The reporter considered the tinnitus and debility to be possibly related to TWINRIX. Additional details were provided as follows: This case was reported via email was shared with GSK Corporate Media team via the Corporate Media Enquiries function on GSK.com. The age at vaccination was not reported. As the patient was traveling in August 2018, the patient was administered with a TWINRIX vaccine. Sadly the patient became a victim of strong tinnitus with all signs pointing to this vaccine as the culprit. This was debilitating for the patient and she needed a solution as this was not mentioned as side effect. The patient wanted to know if there was any way to do anything to reverse the effects of this vaccine. As the patient did not work in the medical field, she did not understand why she was advised to even asked to had a Hepatitis B vaccine in her system. The patient was praying this would not turning into nerve damage and she needed immediate support.
Patient's eye and face swelled shortly after vaccine administration. School nurse was informed that the child was taken to the ED at hospital. Childs face would swell gain as BENADRYL wore off.
The day after the second dose I felt sweaty hot and nauseous. I was still really sleepy on the third day. My eye started hurting and I could hear a buzzing sound in both ears. It got worse and worse by day six and I was having trouble seeing out of my right eye. It was really painful underneath my eye on the inside corner with swelling on the top lid. The Steroids seemed to help the problem with my eye. The doctor suspected Bells Palsy. On week two I was prescribed steroids from Lymphadenopathy. I still have the ringing in my ears which is increasing after it had subsided for a little time. I also felt pressure in my ears which is very uncomfortable. Whenever I stop taking the Steroids the ringing in my ears returns like Tinnitus. I plan to reach out to a doctor again because the ringing in my ears has returned after it had improved but was still present after 10 weeks. I did not have any of the same symptoms after the same dose. I have seen a lot of professionals.
48 hrs post vax c/o h/a; 10 days post vax c/o dizzy spells seen @ ER dx vertigo as a result of flu shot
69-year-old male with no history of shoulder problems presenting with pain, weakness, difficulties moving his arm since he received his Covid vaccine in March.  It never got better and in fact it got worse when he got his second vaccine.  Since then he has been working with many alternative modalities to try to improve the pain but he is getting frustrated by his lack of range of motion.  He worries that the weakness could lead to injury if he were to fall and try to brace himself. Exam today reveals decrease pain to motion secondary to pain in abduction, internal rotation.  There is no obvious deformity of the shoulder joint or acromioclavicular joint.  There is no crepitus.  Strength is intact.
3/20/10 screaming uncontrollably. 3/23/10 vomiting began. 3/24/10 watery stools.
Body aches with Humira; Not feeling well after receiving second dose of Covid-19 vaccine; Dizziness after receiving second dose of Covid-19 vaccine; This spontaneous case was reported by a physician and describes the occurrence of PAIN (Body aches with Humira), MALAISE (Not feeling well after receiving second dose of Covid-19 vaccine) and DIZZINESS (Dizziness after receiving second dose of Covid-19 vaccine) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Psoriatic arthritis.    No Medical History information was reported.   In November 2020, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) 40 milligram every two weeks. On 19-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Feb-2021, the patient experienced PAIN (Body aches with Humira), MALAISE (Not feeling well after receiving second dose of Covid-19 vaccine) and DIZZINESS (Dizziness after receiving second dose of Covid-19 vaccine). At the time of the report, PAIN (Body aches with Humira), MALAISE (Not feeling well after receiving second dose of Covid-19 vaccine) and DIZZINESS (Dizziness after receiving second dose of Covid-19 vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported by investigator No treatment medications provided by the reporter. Events are recovered in month of february 2021.   This case was linked to MOD-2021-079906 (Patient Link).
On Tuesday January 18th 2022, patient presented herself, along with her legal guardian to the Health Dept covid vaccination clinic for her second dose of covid vaccination. Legal Guardian, was given an adult Pfizer form for fill out on behalf of patient, as patient is 15 years old. When patient came up for vaccination I noted that she had Moderna indicated as her first dose on her vaccination record card. Patient's paperwork from her first covid vaccination was pulled from the storage files to check if the card was an error. The vaccination record shows patient got Moderna lot # 077C21B on 12.20.21 administered by an agency registered nurse, as her first dose. The electronic record showed the same. I did not proceed with further vaccination and reported the error to my supervisor and then further in an e mail as requested. I advised legal guardian, that we would await further instruction on how to move forward.  As per request I am completing the ARIA and VAERS.
Intermittent soreness left upper arm of 10 to 20 minute duration. No reason just comes and goes occasionally but has been doing so now for several months.
Varicella-like rash all over - face, neck, body, arms, legs. No fevers.
Came into clinic for PPD reading.  Patient states left upper arm red, swollen and hot to touch.
experiencing dizziness /  lightheadedness; This case was reported by a consumer via call center representative and described the occurrence of light headedness in a 65-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included blood cholesterol increased (high cholesterol).   On 27th November 2020, the patient received the 1st dose of Shingrix (intramuscular). On 27th November 2020, less than a day after receiving Shingrix, the patient experienced light headedness. On an unknown date, the outcome of the light headedness was not recovered/not resolved.   It was unknown if the reporter considered the light headedness to be related to Shingrix.  Additional details were provided as follows: The patient had reported the case for himself. The patient received vaccine in his right upper arm and he experienced dizziness and lightheadedness at the evening of getting the vaccine. These adverse events were lasted for the past seven days and are were still ongoing at the time of reporting. The patient had been feeling dizzy every day since getting the vaccine and he had visited his doctor and had bloodwork done; he was told by his doctor that everything was fine and he was not sure what might have caused the adverse reactions. The bloodwork showed high cholesterol, which patient had for a long time. The patient gave permission to follow-up with their health care professional and unable to provide health care professional's email/fax at the time of reporting.
She describes the predominant symptom as bilateral arm weakness (both arms at same time),  bilateral facial ('T zone') numbness, and slurred speech. Symptoms initially began Friday, 9/15/2017. Symptoms came on gradually 5 days after receiving TDaP vaccine. Associated symptoms include dysphagia, neurasthenia, both hands involuntarily clenching in flexion contracture, shortness of breath, palpitations. Treatment consists of physical and speech therapy; she has recovered 95% back to baseline as of current date.
Information has been received from a physician concerning a 13 week old male with no reported pre-existing allergies, birth defects or medical conditions, who on 23-FEB-2007, received an intramuscular first dose in his thigh of measles virus vaccine live (Enders-Edmonston) (+) mumps virus (lot # 654544/0700F). It was reported that on 24-FEB-2007, he developed a questionable local reaction, but another shot (vaccine and or medication not specified) was given in the same area, not sure which reacted. There was no reported illness at the time of vaccination and no reported adverse events following prior vaccination. Current patient status was not reported. There were no laboratory or diagnostic test performed. A product quality complaint was not reported. No further information was available. Additional information has been requested.
Low grade fever diffuse aches, local redness and swelling at injection site. Dr. suggested MOTRIN prn and a follow-up appt if needed - pt. did not return.
I had the shot and I still got the shingles/ suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a adult patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The patient self reported the case. The age at vaccination was not reported. The age group was not reported but was selected as adult as per vaccine indication. The patient had the shingles vaccine shot and still got the shingles. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset for target disease and laboratory confirmation were unknown at the time of reporting.
Immediately after vaccine administration, Patient reported feeling warm and requested for a chair to elevate her legs. Patient was provided with a chair and elevated her legs with assistance. While elevating legs, patient began leaning to the side and sliding down in the  chair. RN held patient to prevent a fall and called for help. We tried communicating with patient but she only produced humming sounds. Approximately 10 seconds later patient verbalized her name upon questioning.  Patient reported later that she "blacked out" while her eyes were open. Patient verbalized that she has a history of sweating and vaso-vagal response to blood draws and vaccine administrations.
c/o localized oval-shaped left upper arm erythema and induration, non-tender, non-pruritic.
10/17: Redness and swelling at the injection. 10/17: Past 6 PM fever 100.5 degrees F, inflammation at the site of injection. (ADVIL 400mg). 10/18: No fever, myalgia, inflammation at the site. (Ice pac, ADVIL and rest).
Right glutinous numbness/burning 1 hr after Hepatitis B injection with increasing discomfort locally to radiating to back. Prior local reaction at deltoid with # 1 Hepatitis B.
Hot; Swelling at injection site and bellow right elbow (egg sized lump); Painful to the touch; A spontaneous report was received from a consumer concerning a 64-years-old male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced swelling at injection site and bellow right elbow (egg sized lump), hot, painful to the touch, now was down to his forearm as twice as big.  The patient's medical history fell and hit his elbow really bad, he had bruise and really hurt. Concomitant medications reported were levothyroxine and celecoxib, both were used for an unknown indication.  On 25-JAN-2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot batch: 057G20A) intramuscularly for prophylaxis of COVID-19 infection.  On 26-JAN-2021, the patient experienced the events swelling at injection site and below right elbow (egg sized lump), hot, painful to the touch. On an unknown date, the physician recommended ice plus ibuprofen and to keep the arm elevated. They drew a circle around the swelling to see if it got bigger and it did. Now was down to his forearm - twice as big.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of the events, swelling at injection site and bellow right elbow (egg sized lump), hot, painful to the touch, now was down to his forearm as twice as big was unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
He got an ulcerative colitis flare that started around the time of the first vaccine. This led to significant iron deficiency anemia. Approximately 5-6 weeks after dose 2 of vaccine patient had a politeal artery thrombosis resulting in prolonged hospitalization. He did end up getting a colectomy as well. No family history of thrombosis.
3/4/2023 I got up and felt pain in my left ear. It felt like there was a big slug of water in my ear. On 3/6/23 I had an appointment with my doctor. He said my ear look nasty and started me on AUGMENTIN and ear drops that contained an antibiotic and a steroid. I started the medications that day. Treatment continues and it has not responded to the treatment. I had a follow up with my doctor and he agreed it had not resolved and I was referred to ENT. I saw the ENT doctor on 3/9/23. He said I was on good treatment, but he added prednisone. I went back on 3/13/23 for a hearing test. This showed significant hearing loss in my left ear. This morning, the ENT doctor and I talked over the phone. He wants me to finish the medications and follow up next week. I am still not seeing any improvement. Two days before I started having these symptoms, I had visited a water park.
Face numb and swollen, rash around neck, chin/cheeks. Had to take steroids to get rid of.
This spontaneous report was received from a medial assistant and refers to a 2 and a half year old patient of unknown gender. No information regarding the patient's pertinent medical history, concomitant medications and drug reactions or allergies was reported. On an unknown date in September 2018, the patient was vaccinated with a dose of GARDASIL 9, intramuscularly ( xact dose, dose number, lot and expiration date were not provided). No adverse effect was reported.
02/20/23 presents to ED for "sore throat, nonproductive cough and generalized fatigue". PMHx of "HTN, HLD, CKD"
Received around 11am, some dizziness and tunnel vision about 10 minutes after while sitting, resolved within minutes.  That evening: fatigue, mild arm sore Overnight: shaking, chills, fever, more severe arm soreness Following day: fatigue, fever, chills Beginning that evening: fever/chills resolved, started having  palpitations and dizziness with some shortness of breath. Had these for about 3 more days primarily at rest. Self resolved  Vaccine #2 3 weeks later: medicated with Tylenol and Motrin q4 hours, some breakthrough chills and joint pain overnight, mild arm soreness. Self resolved the following day. Have continued bruising at injection site 3 weeks later   Continue to have some intermittent palpitations and dyspnea. Not present prior to vaccine 1.
Initial report received from a consumer on 28 October 2010. A 79-year-old female patient, with a medical history of bilateral cataract removal, diabetes and asthma, receive on 07 October 2010 an injection (route and site not provided) of INFLUENZA VACCINE, lot number not reported. On 07 October 2010, the patient developed muscle aches and pains, dry mouth, nausea, difficulty walking, weakness, chest congestion and shortness of breath. Her concomitant medications included PROAIR and insulin. The patient notified her physician and no medical intervention was given. The patient's symptoms were reported as resolving. Follow-up information was received 11 February 2011 from a health care professional. The patient had additional medical history of psoriasis. According to the reporter, the patient recovered (date not reported). No additional information was provided. Follow-up information was received 04 April 2011 from a health care professional. The patient received an intramuscular left arm injection of FLUZONE, lot number UT3569AA. No further information was received at the time of the report. The patient's outcome remained recovered. Documents held by sender: None.
looked at the printout of my Vaccine history the 5th injection was listed as Invalid; No Adverse event; This spontaneous case was reported by a patient and describes the occurrence of CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO DEVICE USE ERROR (looked at the printout of my Vaccine history the 5th injection was listed as Invalid) and NO ADVERSE EVENT (No Adverse event) in a  patient of an unknown age and gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO DEVICE USE ERROR (looked at the printout of my Vaccine history the 5th injection was listed as Invalid) and NO ADVERSE EVENT (No Adverse event). At the time of the report, CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO DEVICE USE ERROR (looked at the printout of my Vaccine history the 5th injection was listed as Invalid) and NO ADVERSE EVENT (No Adverse event) outcome was unknown.            No concomitant medication was provided.  It was reported that patient was going to Italy later this month. When the patient looked at the printout of Vaccine history it was reported that the 5th injection was listed as "Invalid".  No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 08-Jun-2023: Follow up received and included nonsignificant information.
Patient was under age for the vaccine, moderna vaccine is only for people 18 years of age and above. Patient at the time was 17 years old. She was given her first dose at a different location by accident and we gave her second dose for her to complete the series.
Case rec'd first covid vaccination on 12/20/2020, Second Vaccination on 1/8/2021. Tested positive for Covid-19 by PCR on 2/9/21 No symptoms.
Employee felt sore in her left arm after the vaccination but thought the soreness would go away. Employee states the pain  in her left arm became progressively worse in April and May and she is unable to raise her left arm above shoulder.
Pt. received one dose of varicella vaccine on 4/22/99. He never received a 2nd dose. Seen in ER & then in pediatric office for herpes zoster.
This case was reported by a nurse via call center representative and described the occurrence of injection site erythema in a 62-year-old female patient who received SHINGRIX for prophylaxis. Concomitant products included HUMIRA. On 17th May 2018, the patient received SHINGRIX. On 17th May 2018, less than a day after receiving SHINGRIX, the patient experienced injection site erythema, injection site swelling, injection site pain, fever, chills, headache, stomach pain and fatigue. On an unknown date, the outcome of the injection site erythema, injection site swelling, injection site pain, fever, chills, headache, stomach pain and fatigue were recovered/resolved. It was unknown if the reporter considered the injection site erythema, injection site swelling, injection site pain, fever, chills, headache, stomach pain and fatigue to be related to SHINGRIX. Additional details were reported as follows: The evening of vaccination date, the patient began to experience injection site reactions in the arm. The events all resolved in about 2 days.